RIG
ABMD

Ramiah Investment Group’s Abiomed Inc ABMD Stock Holding History

Ramiah Investment Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,867
Closed -$929K – 101
2020
Q4 		$929K Sell
2,867
-5,314
-65% -$1.47M 0.77% 26
2020
Q3 		$2.27M Buy
8,181
+5,166
+171% +$1.49M 2.2% 8
2020
Q2 		$728K Buy
3,015
+38
+1% +$7.63K 0.77% 27
2020
Q1 		$432K Buy
+2,977
New +$494K 0.77% 30

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Ramiah Investment Group's ABMD Position: Q1 2021 in Review

Ramiah Investment Group sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 2,867 shares — an estimated $929K sold.

Ramiah Investment Group first reported a position in ABMD in Q1 2020 and held it in 4 quarters. The position peaked at $2.27M in Q3 2020. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • Ramiah Investment Group reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
  • Ramiah Investment Group sold 2,867 Abiomed Inc shares in Q1 2021, an estimated $929K.
  • Ramiah Investment Group first reported a position in Abiomed Inc in Q1 2020 and held it in 4 quarters.
  • Ramiah Investment Group's Abiomed Inc position peaked at $2.27M in Q3 2020.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Ramiah Investment Group's 13F filing for Q1 2021, filed 29 May 2026.